Abstract:BACKGROUND: The mononegavirus superfamily (Mononegavirales) comprises three families, Rhabdoviridae, Paramyxoviridae and Filoviridae. These viruses possess a single stranded negative sense RNA as the genome. Recent success in the recovery of infectious virus from a transfected cDNA of mononegaviruses including Sendai virus, a prototypic paramyxovirus, is opening the possibility of their genetic engineering. However, infectious viruses have been recovered only by initiating the infectious cycle with cDNA directing the synthesis of antigenomic positive sense (+)RNA. Starting with genomic negative sense (-)RNA has been unsuccessful. Furthermore, the recovery efficiency has often been extremely low.RESULTS: We describe here an analogous system that allows recovery of Sendai virus at a high rate, from cells in which the transfected cDNA and plasmids to support the synthesis of viral nucleocapsid protein and RNA polymerases are coexpressed by vaccinia virus-driven bacteriophage T7 polymerase. Our system was able to recover the virus from cDNA directing not only (+)RNA but also (-)RNA. Moreover, using this system, we succeeded in recovery of the virus by transfection of in vitro synthesized (+)RNA or (-)RNA. This improved virus recovery appeared to be accomplished by supplying the supporting plasmids at an optimal ratio and by minimizing the cytopathic effect of the vaccinia virus by specific inhibitors. In addition, it was probably critical that our cDNAs were constructed to generate viral authentic RNAs without adding T7 promoter-specific nucleotides to the 5' ends. An immediate application of the system was demonstrated by the creation of a candidate vaccine strain with a predetermined attenuating mutation in the cleavage-activation site of the viral fusion glycoprotein.CONCLUSION: We have established methods which greatly improve the recovery of Sendai virus from cDNA. There is essentially no absolute obstacle to recovery of the virus from the (-)RNA template. Even the complete full length RNA chain in the naked form appears to be properly encapsidated to become a functional template.

An engineered ligand-responsive Csy4 endoribonuclease controls transgene expression from Sendai virus vectors

A temperature-sensitive and less immunogenic Sendai virus for efficient gene editing

Inhibition Of Sars-Cov Gene Expression By Adenovirus-Delivered Small Hairpin Rna

A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs

Genetic engineering strategy for generating a stable dsRNA virus vector using a virus-like codon-modified transgene

Development of an RNA virus-based episomal vector with artificial aptazyme for gene silencing

A temperature-sensitive and interferon-silent Sendai virus vector for CRISPR-Cas9 delivery and gene editing in primary human cells

Ribonuclease P-mediated inhibition of human cytomegalovirus gene expression and replication induced by engineered external guide sequences.

Engineered External Guide Sequences Effectively Block Viral Gene Expression and Replication in Cultured Cells

Generation of a Caged Lentiviral Vector Through an Unnatural Amino Acid for Photo-Switchable Transduction

Broadening The Versatility Of Lentiviral Vectors As A Tool In Nucleic Acid Research Via Genetic Code Expansion

Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense

Significantly Improved Recovery Of Recombinant Sonchus Yellow Net Rhabdovirus By Expressing The Negative-Strand Genomic Rna

Lentiviral Delivery of Proteins for Genome Engineering

Design and synthesis of a Tat-related gene transporter: a tool for carrying the adenovirus vector into cells.

An Improved Tet-on System for Gene Expression in Neurons Delivered by a Single Lentiviral Vector.

653. the Controlled Transgene Expression in Oncolytic Adenoviral Vectors with Major Late Promoter for Therapy of Cancer

The Dual-Pseudotyped Lentiviral Vector with VSV-G and Sendai Virus HN Enhances Infection Efficiency through the Synergistic Effect of the Envelope Proteins

Adeno-Associated Virus Engineering and Load Strategy for Tropism Modification, Immune Evasion and Enhanced Transgene Expression

Development of novel SARS-CoV-2 viral vectors

Rationally designed synthetic vectors for therapeutic nucleic acid delivery against human cytomegalovirus infection